The E3 ubiquitin ligase adaptor cereblon targets the C-terminal cyclic imide degron
Ontology highlight
ABSTRACT: Global quantitative proteomics of cells treated with the immunomodulatory drug pomalidomide or dipeptide degrons; global quantitative proteomics of cells treated with heterobifunctional degraders embedded with thalidomide or cyclic imide degrons; gloabl quantitative proteomics of red blood cells to search for the presence of C-terminal cyclic imide modifications on hemoglobin.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Erythrocyte, B Cell, Cell Suspension Culture, Cell Culture
DISEASE(S): Multiple Myeloma
SUBMITTER:
Christina Woo
LAB HEAD: Christina Woo
PROVIDER: PXD025413 | Pride | 2022-07-28
REPOSITORIES: Pride
ACCESS DATA